Current evidence on the use of anti-RAAS agents in congenital or acquired solitary kidney

Rational: The inhibition of renin–angiotensin–aldosterone system (RAAS) is a major strategy for slowing the progression of chronic kidney disease (CKD). The utility of anti-RAAS agents in patients with congenital or acquired solitary kidney is still controversial. Objective: A systematic literature...

Descripción completa

Detalles Bibliográficos
Autores principales: Simeoni, Mariadelina, Armeni, Annarita, Summaria, Chiara, Cerantonio, Annamaria, Fuiano, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
State-Of-The-Art Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446147/
https://www.ncbi.nlm.nih.gov/pubmed/28805480
http://dx.doi.org/10.1080/0886022X.2017.1361840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446147/
https://www.ncbi.nlm.nih.gov/pubmed/28805480
http://dx.doi.org/10.1080/0886022X.2017.1361840

Ejemplares similares